Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 1994-05-01 (32 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE GRAU-DU-ROI (30240), Gard
PHARMACIE BOUCOIRAN : revenue, balance sheet and financial ratios
PHARMACIE BOUCOIRAN is a French company
founded 32 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE GRAU-DU-ROI (30240),
this company of category PME
shows in 2016 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BOUCOIRAN (SIREN 398081372)
Indicator
2024
2023
2022
2016
2015
Revenue
N/C
N/C
N/C
2 257 471 €
2 259 109 €
Net income
225 612 €
149 742 €
280 797 €
189 574 €
172 374 €
EBITDA
N/C
N/C
N/C
250 192 €
228 072 €
Net margin
N/C
N/C
N/C
8.4%
7.6%
Revenue and income statement
In 2024, PHARMACIE BOUCOIRAN generates positive net income of 226 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 172 k€ -> 226 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
225 612 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1.46%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
84.802%
Solvency indicators evolution PHARMACIE BOUCOIRAN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2022
2023
2024
Debt ratio
16.765
14.307
1.851
0.789
1.46
Financial autonomy
74.079
76.675
85.226
78.687
84.802
Repayment capacity
1.393
1.153
None
None
None
Cash flow / Revenue
7.284%
8.365%
None%
None%
None%
Sector positioning
Debt ratio
1.462024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of PHARMACIE BOUCOIRAN (1.46) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
84.8%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+10 pts over 3 years
In 2024, the financial autonomy of PHARMACIE BOUCOIRAN (84.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BOUCOIRAN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2022
2023
2024
Operating WCR
208 132 €
151 386 €
0 €
0 €
0 €
Inventory turnover (days)
27
24
0
0
0
Customer payment term (days)
7
4
0
0
0
Supplier payment term (days)
43
39
0
0
0
Positioning of PHARMACIE BOUCOIRAN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE BOUCOIRAN is estimated at
3 149 710 €
(range 2 193 408€ - 4 712 146€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2193k€3149k€4712k€
3 149 710 €Range: 2 193 408€ - 4 712 146€
NAF 5 année 2024
Valuation method used
Net Income Multiple
225 612 €
×
14.0x
=3 149 710 €
Range: 2 193 408€ - 4 712 147€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BOUCOIRAN with other companies in the same sector:
Frequently asked questions about PHARMACIE BOUCOIRAN
What is the revenue of PHARMACIE BOUCOIRAN ?
The revenue of PHARMACIE BOUCOIRAN in 2016 is 2.3 M€.
Is PHARMACIE BOUCOIRAN profitable?
Yes, PHARMACIE BOUCOIRAN generated a net profit of 226 k€ in 2024.
Where is the headquarters of PHARMACIE BOUCOIRAN ?
The headquarters of PHARMACIE BOUCOIRAN is located in LE GRAU-DU-ROI (30240), in the department Gard.
Where to find the tax return of PHARMACIE BOUCOIRAN ?
The tax return of PHARMACIE BOUCOIRAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BOUCOIRAN operate?
PHARMACIE BOUCOIRAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart